CA Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences Inc
- 65.080
- -2.380-3.53%
15min DelayMarket Closed Dec 3 15:53 ET
453.90MMarket Cap-73954P/E (TTM)
66.540High63.840Low402Volume64.750Open67.460Pre Close26.15KTurnover108.00052wk High0.02%Turnover Ratio6.97MShares1.29052wk Low-0.88EPS TTM173.82MFloat Cap108.000Historical HighLossP/E (Static)2.67MShs Float1.290Historical Low-1.98EPS LYR4.00%Amplitude--Dividend TTM74.38P/B1Lot Size--Div YieldTTM
Bright Minds Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M | -85.63%-13.59M | 10.92%-2.13M |
| Net income from continuing operations | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Operating gains losses | 69.64%-39.61K | -59.39%2.17K | 500.01%42.3K | 117.52%45.35K | 417.62%163.44K | -467.93%-130.47K | -23.72%5.33K | 103.68%7.05K | -15.66%-258.82K | 66.21%-51.46K |
| Depreciation and amortization | 0.00%18.11K | -0.01%18.11K | 0.01%18.11K | 1,100.10%72.45K | 200.02%18.11K | --18.11K | --18.11K | --18.11K | --6.04K | --6.04K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2K | ---- |
| Remuneration paid in stock | -22.56%183.94K | 656.58%226.64K | -54.78%218.95K | 31.66%1.15M | 1,238.78%400.5K | -19.04%237.54K | -89.70%29.96K | 85.55%484.14K | -0.63%875.06K | -92.06%29.92K |
| Other non cashItems | -72.88%1.24K | -60.14%2.13K | -50.93%2.97K | -32.88%19.75K | 74.23%3.79K | --4.58K | --5.33K | --6.06K | -92.02%29.42K | --2.17K |
| Change In working capital | 52.35%-153.43K | -200.16%-479.99K | 168.74%579.85K | -230.05%-941.72K | -130.26%-255.36K | 35.77%-322K | -11.94%479.25K | -419.24%-843.6K | 136.58%724.13K | 233.34%843.75K |
| -Change in receivables | 862.32%536.01K | -2,061.29%-508.21K | -108.35%-8.06K | 360.33%118.8K | 173.02%66.7K | -162.80%-70.31K | 197.00%25.91K | 344.04%96.5K | 58.57%-45.63K | -184.01%-91.34K |
| -Change in prepaid assets | -215.89%-43K | 181.02%16.76K | -169.82%-4.38K | 3,519.30%136.74K | 235.54%114.04K | 662.24%37.11K | -136.29%-20.68K | -75.93%6.27K | 104.20%3.78K | -109.65%-84.14K |
| -Change in payables and accrued expense | -123.84%-646.44K | -97.58%11.46K | 162.58%592.29K | -256.30%-1.2M | -142.79%-436.1K | 53.28%-288.8K | -7.76%474.02K | -535.25%-946.38K | 51.34%765.99K | 213.21%1.02M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M | -85.63%-13.59M | 10.92%-2.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2.18%-21.96K | -2.17%-21.96K | -61.05%878.04K | -57.86%2.19M | -100.43%-21.65K | -279.08%-21.49K | -1,376.13%-21.49K | 1,806.39%2.25M | -80.06%5.2M | 52,308.82%5.06M |
| Net issuance payments of debt | -2.18%-21.96K | -2.17%-21.96K | -2.18%-21.96K | -1,102.35%-86.11K | -187.14%-21.65K | ---21.49K | 32.84%-21.49K | ---21.49K | ---7.16K | --24.84K |
| Net common stock issuance | --0 | --0 | -26.08%900K | -69.83%1.22M | --0 | --0 | --0 | --1.22M | -85.46%4.03M | --4.03M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -44.87%1.09M | --0 | --0 | --0 | 817.78%1.09M | 1,576.70%1.97M | 19,050.48%1.84M |
| Net other financing activities | ---- | ---- | ---- | 96.63%-26.98K | --0 | --0 | --0 | ---26.98K | 55.72%-799.98K | ---833.66K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2.18%-21.96K | -2.17%-21.96K | -61.05%878.04K | -57.86%2.19M | -100.43%-21.65K | -279.08%-21.49K | -1,376.13%-21.49K | 1,806.39%2.25M | -80.06%5.2M | 52,308.82%5.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.15%11.63M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M | -41.15%11.63M | 2,370.22%19.76M | -60.74%8.64M |
| Current changes in cash | 113.05%218.2K | 46.09%-827.05K | 113.67%55.96K | 42.38%-4.83M | -141.53%-1.22M | 41.33%-1.67M | 57.90%-1.53M | 91.53%-409.36K | -144.78%-8.39M | 222.36%2.94M |
| Effect of exchange rate changes | -69.64%39.61K | 59.39%-2.17K | -500.01%-42.3K | -117.52%-45.35K | -417.62%-163.44K | 467.93%130.47K | 23.72%-5.33K | -103.68%-7.05K | 15.66%258.82K | -66.21%51.46K |
| End cash Position | -23.86%6.19M | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.97%6.75M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M | -41.15%11.63M | -41.15%11.63M |
| Free cash from | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M | -85.63%-13.59M | 10.92%-2.13M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data